APA (7th ed.) Citation

Oh, E. Y., Bae, S. K., Kwon, J. W., You, M., Lee, D. C., & Lee, M. G. (2007). Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA‐8159, an erectogenic, in rats. British journal of pharmacology, 151(1), 24-34. https://doi.org/10.1038/sj.bjp.0707192

Chicago Style (17th ed.) Citation

Oh, E Y., S K. Bae, J W. Kwon, M. You, D C. Lee, and M G. Lee. "Pharmacokinetic and Pharmacodynamic Consequences of Inhibition of Terazosin Metabolism via CYP3A1 And/or 3A2 by DA‐8159, an Erectogenic, in Rats." British Journal of Pharmacology 151, no. 1 (2007): 24-34. https://doi.org/10.1038/sj.bjp.0707192.

MLA (9th ed.) Citation

Oh, E Y., et al. "Pharmacokinetic and Pharmacodynamic Consequences of Inhibition of Terazosin Metabolism via CYP3A1 And/or 3A2 by DA‐8159, an Erectogenic, in Rats." British Journal of Pharmacology, vol. 151, no. 1, 2007, pp. 24-34, https://doi.org/10.1038/sj.bjp.0707192.